"Reverse Blalock-Taussig shunt": application in single ventricle hybrid palliation

J Thorac Cardiovasc Surg. 2013 Aug;146(2):352-7. doi: 10.1016/j.jtcvs.2012.11.029. Epub 2012 Dec 8.

Abstract

Objective: Retrograde aortic arch malperfusion after ductal stenting can be life-threatening after univentricular hybrid palliation. Arch perfusion can be maintained with a main pulmonary artery to innominate artery shunt placed during the stage I procedure: a "reverse Blalock-Taussig shunt."

Methods: A retrospective review of 37 infants who underwent hybrid palliation from January 2004 to March 2010 was performed. The infants were divided into 2 groups, those with (group I, n = 16) and those without (group II, n = 21) a reverse Blalock-Taussig shunt.

Results: At the initial palliation, no differences were found in the demographics, systolic or diastolic pressures, or ventricular or atrioventricular valve function between the 2 groups. Group I had more infants with aortic atresia (P < .01) and smaller ascending aortas (P < .01). Before stage II, the retrograde aortic Doppler flow velocity increased in group I (P < .01) and was unchanged in group II. The reintervention rates before stage II were similar between the 2 groups. Before stage II, the ventricular end-diastolic pressure, left and right pulmonary artery pressures and diameters, and mixed venous and arterial saturations were similar between the 2 groups. The complication rates between the 2 groups were not significantly different, although a nonsignificant trend toward more neurologic complications was noted in group I. The Kaplan-Meier survival estimate at 1 year was similar between the 2 groups (63% for group I vs 71% for group II).

Conclusions: The presence of a reverse Blalock-Taussig shunt was not associated with more adverse events than those without. Gradual retrograde arch obstruction occurs commonly in palliated infants with aortic atresia. A reverse Blalock-Taussig shunt might play an important role to address the potential of retrograde obstruction, augmenting arch blood flow.

Keywords: 20; 26.1.1; AVVR; BT; Blalock-Taussig; ECMO; PA; PVR; atrioventricular valve regurgitation; extracorporeal membrane oxygenation; pulmonary artery; pulmonary valve regurgitation; revBT; reverse BT.

MeSH terms

  • Aorta, Thoracic / physiopathology
  • Blalock-Taussig Procedure / adverse effects
  • Blalock-Taussig Procedure / methods*
  • Blalock-Taussig Procedure / mortality
  • Blood Flow Velocity
  • Brachiocephalic Trunk / physiopathology
  • Brachiocephalic Trunk / surgery*
  • Female
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / mortality
  • Heart Defects, Congenital / physiopathology
  • Heart Defects, Congenital / surgery*
  • Heart Ventricles / abnormalities
  • Heart Ventricles / physiopathology
  • Heart Ventricles / surgery*
  • Hemodynamics
  • Humans
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Male
  • Palliative Care / methods*
  • Pulmonary Artery / physiopathology
  • Pulmonary Artery / surgery*
  • Regional Blood Flow
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome